The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo

Journal of Clinical Investigation

Volumn 106, Issue 1, 2000, Pages 63-72

  Kishimoto, Koji ^e   Dong, Victor M ^e   Issazadeh, Shohreh ^e   Fedoseyeva, Eugenia V ^e   Waaga, Ana Maria ^e   Yamada, Akira ^a   Sho, Masayuki ^e   Benichou, Gilles ^e   Auchincloss Jr , Hugh ^a   Grusby, Michael J ^b   Khoury, Samia J ^e   Sayegh, Mohamed H ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD40 ANTIGEN;

ALLOGENEIC RESTRICTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL;

EID: 0033917737     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9586     Document Type: Article

References (60)

1. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
2. Abbas, A.K., Murphy, K.M., and Sher, A. 1996. Functional diversity of helper T lymphocytes. Nature. 383:787-793.
3. Takeuchi, T., Lowry, R.P., and Konieczny, B. 1992. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation. 53:1281-1294.
4. Sayegh, M.H., et al. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869-1874.
5. Binder, J., et al. 1996. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts. Transplantation. 61:804-811.
6. Hancock, W.W., et al. 1996. Costimulatory function and expression of CD40 ligand, CD80,and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA. 93:13967-13972.
7. Onodera, K., et al. 1997. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J. Immunol. 158:1572-1581.
8. Dallman, M.J., Shiho, O., Page, T.H., Wood, K.J., and Morris, P.J. 1991. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J. Exp. Med. 173:79-87.
9. Gianello, P.R., et al. 1994. Mechanism of cyclosporin-induced tolerance to primarily vascularized allografts in miniature swine. Effect of administration of exogenous IL-2. J. Immunol. 153:4788-4797.
10. Konieczny, B.T., et al. 1998. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J. Immunol. 160:2059-2064.
11. Dai, Z., Konieczny, B T., Baddoura, F.K., and Lakkis, F.G. 1998. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J. Immunol. 161:1659-1663.
12. Lakkis, F.G., et al. 1997. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J. Immunol. 158:2443-2448.
13. Mottram, P.L., Raisanen-Sokolowski, A., Glysing-Jensen, T., Stein-Oakley, A.N., and Russell, M.E. 1998. Cardiac allografts from IL-4 knockout recipients: assessment of transplant arteriosclerosis and peripheral tolerance. J. Immunol. 161:602-609.
14. Sirak, J.H., Orosz, C.G., Roopenian, D.C., Wakely, E. and VanBuskirk, A.M. 1998. Cardiac allograft tolerance: failure to develop in interleukin-4-deficient mice correlates with unusual allosensitization patterns. Transplantation. 65:1352-1356.
15. Bluestone, J.A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 2:555-559.
16. Thompson, C.B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell. 81:979-982.
17. Sayegh, M.H., and Turka, L.A. 1998. The role of T-cell Costimulatory activation pathways in transplant rejection. N. Engl. J. Med. 338:1813-1821.
18. Linsley, P.S., and Ledbetter, J.A. 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11:191-212.
19. Grewal, I.S., and Flavell, R.A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
20. Kaplan, M.H., Sun, Y.L., Hoey, T., and Grusby, M.J. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature. 382:174-177.
21. Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:313-319.
22. Corry, R.J., Winn, H.J., and Russell, P.S. 1973. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation. 16:343-350.
23. Chen, Z.H. 1991. A technique of cervical heterotopic heart transplantation in mice. Transplantation. 52:1099-1101.
24. Turka, L.A., et al. 1992. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA. 89:11102-11105.
25. Adams, D.H., Tilney, N.L., Collins, J.J., and Karnovsky, M.J. 1992. Experimental graft arteriosclerosis. I. The Lewis-to-F344 allograft model. Transplantation (Baltimore). 53:1115-1119.
26. Russell, M.E., et al., 1996. Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J. Clin. Invest. 97:833-838.
27. Glysing-Jensen, T., Raisanen-Sokolowski, A., Sayegh, M.H., and Russell, M.H. 1997. Chronic blockade of CD28-B7 mediated T cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. Transplantation. 164:1641-1645.
28. Benichou, G., Valujskikh, A., and Heeger, P.S. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162:352-358.
29. Chen, W., Sayegh, M.H., and Khoury, S.J. 1998. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy. J. Immunol. 160:1504-1508.
30. Lin, H., et al. 1998. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. J Exp. Med. 188:199-204.
31. Hancock, W.W., Buelow, R., Sayegh, M.H., and Turka, L.A. 1998. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat. Med. 4:1392-1396.
32. Iwakoshi, N.N., et al. 2000. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J. Immunol. 164:512-521.
33. Piccotti, J. R., et al. 1998. Alloantigen-reactive Th1 development in IL-12-deficient mice. J. Immunol. 160:1132-1138.
34. Strom, T.B., et al. 1996. The Th1/Th2 paradigm and the allograft response. Curr. Opin Immunol. 8:688-693.
35. Piccotti, J.R., Chan, S.Y., VanBuskirk, A.M. Eichwald, E.J., and Bishop, D.K. 1997. Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation. 63:619-624.
36. Field, E.H., Gao, Q., Chen, N.X., and Rouse, T.M. 1997. Balancing the immune system for tolerance: a case for regulatory CD4 cells. Transplantation. 64:1-7.
37. Khoury, S.J., et al. 1995. CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol. 155:4521-4524.
38. Kuchroo, V.K., et al. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707-718.
39. Oosterwegel, M.A., et al. 1999. The role of CTLA-4 in regulating Th2 differentiation. J. Immunol. 163:2634-2639.
40. Keane-Myers, A., Gause, W.C., Linsley, P.S., Chen, S.J., and Wills-Karp, M. 1997. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens. J. Immunol. 158:2042-2049.
41. Larche, M., et al. 1998. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J. Immunol. 161:6375-6382.
42. Padrid, P.A., et al. 1998. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am. J. Respir. Cell. Mol. Biol. 18:453-462.
43. Harris, N.L., Peach, R.J., and Ronchese, F. 1999. CTLA4-Ig inhibits optimal T helper 2 cell development but not protective immunity or memory response to Nippostrongylus brastliensts. Eur. J. Immunol. 29:311-316.
44. Corry, D.B., Reiner, S.L., Linsley, P.S., and Locksley, R.M. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142-4148.
45. Azuma, H., et al. 1996. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc. Natl. Acad. Sci. USA. 93:12439-12444.
46. Chandraker, A., et al. 1998. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J. Clin. Invest. 101:2309-2318.
47. Kaplan, M.H., Wurster, A.L., and Grusby, M.J. 1998. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells. J. Exp. Med. 188:1191-1196.
48. Carter, L.L., and Murphy, K.M. 1999. Lineage-specific requirement for signal transducer and activator of transcription (Stat)4 in interferon gamma production from CD4(+) versus CD8(+) T cells. J. Exp. Med. 189:1355-1360.
49. Tang, A., Judge, T.A., and Turka, L.A. 1997. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity. Eur. J. Immunol. 27:3143-3150.
50. Resetkova, E., et al. 1996. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Thyroid 6:267-273.
51. Durie, F.H., et al. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1328-1330.
52. Li, X.C., Zand, M.S., Li, Y., Xheng, X.X., and Strom, T.B. 1998. On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses. J. Immunol. 161:2241-2247.
53. Newell, K.A., et al. 1999. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells. J. Immunol. 163:2358-2362.
54. Trambley, J., et al. 1999. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J. Clin. Invest. 104:1715-1722.
55. Kirk, A.D., et al. 1997. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94:8789-8794.
56. Kirk, A.D., et al. 1999. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5:686-693.
57. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature, 381:434-438.
58. Wood, K., and Sachs, D.H. 1996. Chimerism and transplantation tolerance: cause and effect [discussion p. 588]. Immunol. Today. 17:584-587.
59. Hamano, K., Rawsthorne, M.A., Bushell, A.R., Morris, P.J., and Wood, K.J. 1996. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation. 62:856-860.
60. Yang, L., DuTemple, B., Gorczynski, R.M., Levy, G., and Zhang, L. 1999. Evidence for epitope spreading and active suppression in skin graft tolerance after donor-specific transfusion. Transplantation. 67:1404-1410.